Through its Fleming Fund Country Grant in Viet Nam, FHI 360 helps to establish the government of the United Kingdom as a key partner to the government of Viet Nam in combating antimicrobial resistance (AMR). The project supports the response to the global threat of AMR and the World Health Organization’s One Health Initiative, which fights AMR in low- and middle-income countries.
Phase 1 of the project took place from May 2019 to April 2024; the project is now in Phase 2.
The project identifies and addresses critical gaps in surveillance of antibiotic-resistant bacteria in Viet Nam, focusing on strengthening AMR and antimicrobial use (AMU) surveillance systems in the human and animal health sectors.
During Phase 1, the project supported the achievement of official recognition, through a Memorandum of Understanding, of the Fleming Fund contributions to AMR management efforts in Viet Nam.
The project also supported the government of Viet Nam in establishing its National One Health Partnership for Zoonotic Disease, 2021–2025, and developing a National One Health Partnership Framework with 31 signatories. The framework was the first official recognition of AMR as a top national priority for Viet Nam.
Further, at the national level, the project supported the government in establishing a new National Steering Committee for Drug Resistance Combat, 2020–2025, and developing a National Strategy for Drug Resistance Combat, 2021–2030. The Vietnamese Ministry of Agriculture and Rural Development officially approved a National Action Plan for AMR Combat in the Agriculture Sector, for which the Fleming Fund project supported development.
Phase 1 also achieved the following accomplishments:
- Helped facilitate the official designation of three National Reference Laboratories for AMR by the Medical Services Administration under Viet Nam’s Ministry of Health.
- Assessed and provided improvement plans for 19 human health and three animal health laboratories.
In Phase 2 of the project, the project will continue to collaborate with government counterparts, in-country experts, partners and international experts to achieve these objectives:
- Strengthen One Health approaches to information-sharing and establish frameworks for governance and policy.
- Strengthen AMR and AMU surveillance systems in the human health sector.
- Strengthen AMR and AMU surveillance systems in the animal health sector.
Climate change is increasing antimicrobial resistance. Here’s what we can do.
